Literature DB >> 17606766

Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis.

Giovanni Palladini, Paola Russo, Mario Nuvolone, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Giampaolo Merlini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17606766     DOI： 10.1182/blood-2007-02-076034

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  41 in total

Review 1.  Amyloidosis and POEMS syndrome.

Authors:  Cheng E Chee; Angela Dispenzieri; Morie A Gertz
Journal:  Expert Opin Pharmacother       Date:  2010-06       Impact factor: 3.889

2.  Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.

Authors:  Vaishali Sanchorawala; Martha Skinner; Karen Quillen; Kathleen T Finn; Gheorghe Doros; David C Seldin
Journal:  Blood       Date:  2007-08-02       Impact factor: 22.113

3.  Amyloidosis 2008 BMT Tandem Meetings (February 13-17, San Diego).

Authors:  Angela Dispenzieri; Giampaolo Merlini; Raymond L Comenzo
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

Review 4.  New insights and modern treatment of AL amyloidosis.

Authors:  Chakra P Chaulagain; Raymond L Comenzo
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

5.  Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach.

Authors:  Giovanni Palladini; Paolo Milani; Andrea Foli; Laura Obici; Francesca Lavatelli; Mario Nuvolone; Riccardo Caccialanza; Stefano Perlini; Giampaolo Merlini
Journal:  Haematologica       Date:  2013-11-08       Impact factor: 9.941

6.  Current treatment of AL amyloidosis.

Authors:  Giovanni Palladini; Giampaolo Merlini
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

7.  Light chain amyloidosis: a case presentation and review.

Authors:  Gavin M Melmed
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-07

8.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

Authors:  Maria Teresa Cibeira; Vaishali Sanchorawala; David C Seldin; Karen Quillen; John L Berk; Laura M Dember; Adam Segal; Frederick Ruberg; Hans Meier-Ewert; Nancy T Andrea; J Mark Sloan; Kathleen T Finn; Gheorghe Doros; Joan Blade; Martha Skinner
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

9.  The amyloidoses: clinical features, diagnosis and treatment.

Authors:  Kelty R Baker; Lawrence Rice
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Jul-Sep

10.  Splenic plasma cells can serve as a source of amyloidogenic light chains.

Authors:  Alan Solomon; Sallie D Macy; Craig Wooliver; Deborah T Weiss; Per Westermark
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.